|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 38, 1434-1442, Copyright © 1997 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
DW Gil, HA Krauss, AM Bogardus and E WoldeMussie
Department of Biological Sciences, Allergan, Inc., Irvine CA 92612, USA.
PURPOSE: To determine the relative levels of the five muscarinic receptor subtypes in the anterior segment of the human eye. METHODS: Antisera selective for each of the five muscarinic receptor proteins were incubated with [3H]-QNB bound receptors solubilized from human iris sphincter, ciliary muscle, and ciliary processes. Precipitation of the radiolabeled receptor-antibody complexes and scintillation counting enabled quantitation of the subtypes in the various tissues. Reverse transcription-polymerase chain reaction was performed on the tissues and cultured smooth muscle cells derived from them. RESULTS: Approximately 60% to 75% of the muscarinic receptors in the human iris sphincter and ciliary body are the m3 subtype. Lower levels (5% to 10%) of the m2 and m4 receptors are present in these tissues. The m1 receptor (7%) was detected in the ciliary processes and iris sphincter and the m5 receptor (5%), which is usually found only in the central nervous system, was present in the iris sphincter. CONCLUSIONS: The m3 subtype is the predominant muscarinic receptor in the anterior segment of the human eye. The extensive heterogeneity of muscarinic receptors makes it difficult to predict whether subtype-selective drugs will have an improved efficacy and side-effect profile.
This article has been cited by other articles:
![]() |
M. Yamada, K. G. Lamping, A. Duttaroy, W. Zhang, Y. Cui, F. P. Bymaster, D. L. McKinzie, C. C. Felder, C.-X. Deng, F. M. Faraci, et al. Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice PNAS, November 9, 2001; (2001) 251542998. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Preiksaitis, P. S. Krysiak, T. Chrones, V. Rajgopal, and L. G. Laurier Pharmacological and Molecular Characterization of Muscarinic Receptor Subtypes in Human Esophageal Smooth Muscle J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 879 - 888. [Abstract] [Full Text] |
||||
![]() |
J. Wang, P. S. Krysiak, L. G. Laurier, S. M. Sims, and H. G. Preiksaitis Human esophageal smooth muscle cells express muscarinic receptor subtypes M1 through M5 Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1059 - G1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Cilluffo, E. Esqueda, and N. A. Farahbakhsh Multiple receptor activation elicits synergistic IP formation in nonpigmented ciliary body epithelial cells Am J Physiol Cell Physiol, September 1, 2000; 279(3): C734 - C743. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsui, D. Motomura, H. Karasawa, T. Fujikawa, J. Jiang, Y. Komiya, S.-i. Takahashi, and M. M. Taketo Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype PNAS, August 15, 2000; 97(17): 9579 - 9584. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Collison, R. A. Coleman, R. S. James, J. Carey, and G. Duncan Characterization of Muscarinic Receptors in Human Lens Cells by Pharmacologic and Molecular Techniques Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2633 - 2641. [Abstract] [Full Text] |
||||
![]() |
M. Yamada, K. G. Lamping, A. Duttaroy, W. Zhang, Y. Cui, F. P. Bymaster, D. L. McKinzie, C. C. Felder, C.-X. Deng, F. M. Faraci, et al. Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice PNAS, November 20, 2001; 98(24): 14096 - 14101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |